Today: 20 May 2026
Oil prices snap higher as U.S.-Iran nuclear talks jolt Brent and WTI; OPEC+ decision next
26 February 2026
2 mins read

Oil prices snap higher as U.S.-Iran nuclear talks jolt Brent and WTI; OPEC+ decision next

NEW YORK, Feb 26, 2026, 13:49 (EST) — Regular session

  • Brent climbed $1.17 to $72.02, while WTI tacked on 87 cents, reaching $66.29
  • U.S.-Iran nuclear negotiations in Geneva drew traders’ attention, with possible supply disruptions or an easing of sanctions in play.
  • U.S. crude stockpiles surged by 16 million barrels last week. OPEC+ is set to meet on March 1.

Oil jumped over $1 on Thursday, bouncing back from earlier swings as traders zeroed in on the U.S.-Iran nuclear negotiations in Geneva. Brent crude ended up $1.17, or 1.65%, at $72.02 per barrel. U.S. West Texas Intermediate tacked on 87 cents, or 1.33%, to $66.29. “Not going so great” for diplomacy, said John Kilduff of Again Capital, reacting to the headlines. Phil Flynn at Price Futures Group warned that any deal lifting sanctions would spell a “bearish” turn for crude. Reuters

These negotiations carry weight—they can tilt supply either way. With U.S. President Donald Trump ramping up military presence in the Middle East and Washington tightening pressure on Tehran’s nuclear ambitions, traders point to the standoff tacking on an estimated $3 to $4 per barrel to U.S. crude. That’s the geopolitical risk premium buyers shell out for potential supply shocks.

Bearish inventory data dropped, but jitters lingered regardless. Oil finished the session nearly flat on Wednesday—even as U.S. crude stockpiles jumped far more than expected. UBS’s Giovanni Staunovo called the report bearish, though he noted the price reaction was “limited” since market attention had shifted. Reuters

The Energy Information Administration reported a 16.0 million barrel jump in U.S. commercial crude inventories for the week ended Feb. 20, lifting the total to 435.8 million barrels. Total commercial petroleum inventories climbed 11.2 million barrels. Gasoline stocks, however, slipped by 1.0 million barrels.

Refinery inputs slipped to 15.7 million barrels per day, a drop of 416,000 barrels from the week before, according to the EIA. Crude imports ticked up, now at 6.7 million barrels per day. Refiners operated at 88.6% of capacity.

OPEC+ is back in focus, with eight main members scheduled to meet March 1. According to three sources cited by Reuters, the group—which counts Russia among its allies and includes the Organization of the Petroleum Exporting Countries—is expected to discuss a 137,000-barrel-per-day output rise for April. That would end a three-month freeze.

Europe’s supply backdrop just got another wrinkle. According to EU sanctions envoy David O’Sullivan, the European Union wants to line up with G7 allies before finalizing a planned ban targeting maritime services tied to Russian seaborne crude exports.

The market’s split. Hints of progress in the Geneva talks—especially anything pointing to sanctions relief—could wipe out the risk premium in a hurry. On the other side, a series of U.S. stock builds keeps traders watching demand signals and refinery throughput.

Markets are now looking to the Geneva talks set for later Thursday for the next key signal. Afterward, attention shifts quickly to the OPEC+ meeting on March 1, where traders will be alert for any changes to output plans as the group faces a market shaken by political tensions and supply concerns.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
IonQ stock price jumps nearly 20% after upbeat 2026 outlook, Romania quantum-network win
Previous Story

IonQ stock price jumps nearly 20% after upbeat 2026 outlook, Romania quantum-network win

Vertiv (VRT) stock price dips from record as AI valuation worries bite again
Next Story

Vertiv (VRT) stock price dips from record as AI valuation worries bite again

Go toTop